Download PDF
Semin Neurol 2009; 29(2): 097-110
DOI: 10.1055/s-0029-1213731
© Thieme Medical Publishers

Movement Disorders Caused by Medical Disease

Brandon Barton1 , S. Elizabeth Zauber1 , Christopher G. Goetz1
  • 1Department of Neurological Sciences, Movement Disorders Section, Rush University Medical Center, Chicago, Illinois
Further Information

Publication History

Publication Date:
15 April 2009 (online)

    Permissions and Reprints

ABSTRACT

Movement disorders often occur in the context of medical illness, whether as the presenting sign of the illness, as a related feature of the underlying disease process, or as a complication of treatment. Early recognition of an underlying medical cause for movement disorders is essential because the treatment and prognosis differ significantly depending on the underlying pathophysiology. Parkinsonism, nonparkinsonian tremor, dystonia, and chorea have a wide variety of etiologies, requiring a careful medical history in the evaluation of new-onset movement disorders. The spectrum of medical diseases associated with these four syndromes is reviewed in this article.

KEYWORDS

Systemic disease - parkinsonism - dystonia - chorea - tremor

REFERENCES

  • 1 García-Moreno J M, Chacón-Peña J. Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion.  Mov Disord. 2003;  18(9) 1058-1059
    CrossrefPubMedSearch in Google Scholar
  • 2 Kim H T, Edwards M J, Lakshmi Narsimhan R, Bhatia K P. Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson.  Parkinsonism Relat Disord. 2005;  11(5) 331-332
    CrossrefPubMedSearch in Google Scholar
  • 3 Li J Y, Yong T Y, Sebben R, Khoo E, Disney A P. Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy.  Nephrology. 2008;  13(1) 68-72
    PubMedSearch in Google Scholar
  • 4 Lee P H, Shin D H, Kim J W, Song Y S, Kim H S. Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema.  Parkinsonism Relat Disord. 2006;  12(2) 93-96
    CrossrefPubMedSearch in Google Scholar
  • 5 Tambyah P A, Ong B K, Lee K O. Reversible parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery.  Am J Med. 1993;  94(4) 444-445
    CrossrefPubMedSearch in Google Scholar
  • 6 Vaamonde J, Legarda I, Jimenez-Jimenez J, Zubieta J L, Obeso J A. Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism.  Mov Disord. 1993;  8(3) 398-400
    CrossrefPubMedSearch in Google Scholar
  • 7 Evans B K, Donley D K. Pseudohypoparathyroidism, parkinsonism syndrome, with no basal ganglia calcification.  J Neurol Neurosurg Psychiatry. 1988;  51(5) 709-713
    CrossrefPubMedSearch in Google Scholar
  • 8 Pearson D W, Durward W F, Fogelman I, Boyle I T, Beastall G. Pseudohypoparathyroidism presenting as severe Parkinsonism.  Postgrad Med J. 1981;  57(669) 445-447
    CrossrefPubMedSearch in Google Scholar
  • 9 Kovacs C S, Howse D C, Yendt E R. Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism.  Arch Intern Med. 1993;  153(9) 1134-1136
    CrossrefPubMedSearch in Google Scholar
  • 10 Manyam B V. What is and what is not ‘Fahr's disease’.  Parkinsonism Relat Disord. 2005;  11(2) 73-80
    PubMedSearch in Google Scholar
  • 11 Costello D J, Walsh S L, Harrington H J, Walsh C H. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.  J Neurol Neurosurg Psychiatry. 2004;  75(4) 631-633
    CrossrefPubMedSearch in Google Scholar
  • 12 Russo N, Edwards M, Andrews T, O'Brien M, Bhatia K P. Hereditary haemochromatosis is unlikely to cause movement disorders: a critical review.  J Neurol. 2004;  251(7) 849-852
    PubMedSearch in Google Scholar
  • 13 Klos K J, Ahlskog J E, Josephs K A, Fealey R D, Cowl C T, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity of magnetic resonance imaging: probable manganese toxicity.  Arch Neurol. 2005;  62(9) 1385-1390
    CrossrefPubMedSearch in Google Scholar
  • 14 Burkhard P R, Delavelle J, Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.  Arch Neurol. 2003;  60(4) 521-528
    CrossrefPubMedSearch in Google Scholar
  • 15 Shulman L M, Minagar A, Weiner W J. Reversal of parkinsonism following liver transplantation.  Neurology. 2003;  60(3) 519
    PubMedSearch in Google Scholar
  • 16 Prevett M C, Rossor M N. Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.  Mov Disord. 1999;  14(3) 523-525
    CrossrefPubMedSearch in Google Scholar
  • 17 Sedel F, Saudubray J M, Roze E, Agid Y, Vidailhet M. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.  J Inherit Metab Dis. 2008;  31(3) 308-318
    CrossrefPubMedSearch in Google Scholar
  • 18 Biegstraaten M, van Schaik I N, Aerts J M, Hollak C E. ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.  J Inherit Metab Dis. 2008;  31(3) 337-349
    CrossrefPubMedSearch in Google Scholar
  • 19 Rogaeva E, Hardy J. Gaucher and Parkinson diseases: unexpectedly related.  Neurology. 2008;  70(24) 2272-2273
    CrossrefPubMedSearch in Google Scholar
  • 20 Evans A H, Costa D C, Gacinovic S et al.. L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: in vivo dopamine transporter and D2 receptor findings.  Mov Disord. 2004;  19(10) 1232-1236
    CrossrefPubMedSearch in Google Scholar
  • 21 Alarcón F, Gimenéz-Roldán S. Systemic diseases that cause movement disorders.  Parkinsonism Relat Disord. 2005;  11(1) 1-18
    CrossrefPubMedSearch in Google Scholar
  • 22 Tse W, Cersosimo M G, Gracies J M, Morgello S, Olanow C W, Koller W. Movement disorders and AIDS: a review.  Parkinsonism Relat Disord. 2004;  10(6) 323-334
    CrossrefPubMedSearch in Google Scholar
  • 23 Hersh B P, Rajendran P R, Battinelli D. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART.  Neurology. 2001;  56(2) 278-279
    CrossrefPubMedSearch in Google Scholar
  • 24 Walker R H, Spiera H, Brin M F, Olanow C W. Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature.  Mov Disord. 1999;  14(2) 262-268
    CrossrefPubMedSearch in Google Scholar
  • 25 Joseph F G, Lammie G A, Scolding N J. CNS lupus: a study of 41 patients.  Neurology. 2007;  69(7) 644-654
    CrossrefPubMedSearch in Google Scholar
  • 26 García-Moreno J M, Chacón J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.  Mov Disord. 2002;  17(6) 1329-1335
    CrossrefPubMedSearch in Google Scholar
  • 27 Khubchandani R P, Viswanathan V, Desai J. Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE.  Lupus. 2007;  16(8) 572-575
    CrossrefPubMedSearch in Google Scholar
  • 28 Kunas R C, McRae A, Kesselring J, Villiger P M. Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease.  J Allergy Clin Immunol. 1995;  96(5 Pt 1) 688-690
    CrossrefPubMedSearch in Google Scholar
  • 29 Lee P H, Joo U S, Bang O Y, Seo C H. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.  Neurology. 2004;  63(2) 395-396
    PubMedSearch in Google Scholar
  • 30 Huang Y C, Lyu R K, Chen S T, Chu Y C, Wu Y R. Parkinsonism in a patient with antiphospholipid syndrome: case report and literature review.  J Neurol Sci. 2008;  267(1–2) 166-169
    CrossrefPubMedSearch in Google Scholar
  • 31 Bogdanova D, Milanov I, Georgiev D. Parkinsonian syndrome as a neurological manifestation of Behçet's disease.  Can J Neurol Sci. 1998;  25(1) 82-85
    PubMedSearch in Google Scholar
  • 32 Hoffman Snyder C, Mishark K H, Caviness J N, Drazkowski J F, Caselli R J. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease.  Arch Neurol. 2006;  63(5) 766-768
    CrossrefPubMedSearch in Google Scholar
  • 33 Golbe L I, Miller D C, Duvoisin R C. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism.  Mov Disord. 1989;  4(2) 147-152
    CrossrefPubMedSearch in Google Scholar
  • 34 Tan J H, Goh B C, Tambyah P A, Wilder-Smith E. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma.  Parkinsonism Relat Disord. 2005;  11(3) 187-191
    CrossrefPubMedSearch in Google Scholar
  • 35 Yu Z, Kryzer T J, Griesmann G E, Kim K, Benarroch E E, Lennon V A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.  Ann Neurol. 2001;  49(2) 146-154
    CrossrefPubMedSearch in Google Scholar
  • 36 Pittock S J, Lucchinetti C F, Lennon V A. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.  Ann Neurol. 2003;  53(5) 580-587
    CrossrefPubMedSearch in Google Scholar
  • 37 Dalmau J, Graus F, Villarejo A et al.. Clinical analysis of anti-Ma2-associated encephalitis.  Brain. 2004;  127(Pt 8) 1831-1844
    CrossrefPubMedSearch in Google Scholar
  • 38 Tan K M, Lennon V A, Klein C J, Boeve B F, Pittock S J. Clinical spectrum of voltage-gated potassium channel autoimmunity.  Neurology. 2008;  70(20) 1883-1890
    CrossrefPubMedSearch in Google Scholar
  • 39 Thomas B, Beal M F. Parkinson's disease.  Hum Mol Genet. 2007;  16 R183-R194
    CrossrefPubMedSearch in Google Scholar
  • 40 Lees J A. Secondary Parkinson's syndromes. In: Jankovic J, Tolosa E Parkinson's Disease & Movement Disorders. 5th ed. Philadelphia, PA; Lippincott Williams & Wilkins 2007: 213-224
    Search in Google Scholar
  • 41 Stepens A, Logina I, Liguts V et al.. A parkinsonian syndrome in methcathinone users and the role of manganese.  N Engl J Med. 2008;  358(10) 1009-1017
    CrossrefPubMedSearch in Google Scholar
  • 42 Choi I S. Parkinsonism after carbon monoxide poisoning.  Eur Neurol. 2002;  48(1) 30-33
    CrossrefPubMedSearch in Google Scholar
  • 43 Dietemann J L, Reimund J M, Diniz R LFC et al.. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition.  Neuroradiology. 1998;  40(12) 793-796
    CrossrefPubMedSearch in Google Scholar
  • 44 Wenning G K, Kiechl S, Seppi K et al.. Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study.  Lancet Neurol. 2005;  4(12) 815-820
    CrossrefPubMedSearch in Google Scholar
  • 45 Esper C D, Factor S A. Failure of recognition of drug-induced parkinsonism in the elderly.  Mov Disord. 2008;  23(3) 401-404
    CrossrefPubMedSearch in Google Scholar
  • 46 Ala A, Walker A P, Ashkan K, Dooley J S, Schilsky M L. Wilson's disease.  Lancet. 2007;  369(9559) 397-408
    CrossrefPubMedSearch in Google Scholar
  • 47 Pfeiffer R F. Wilson's disease.  Semin Neurol. 2007;  27(2) 123-132
    Thieme ConnectPubMedSearch in Google Scholar
  • 48 Geyer H L, Bressman S B. The diagnosis of dystonia.  Lancet Neurol. 2006;  5(9) 780-790
    CrossrefPubMedSearch in Google Scholar
  • 49 Gijtenbeek J M, van den Bent M J, Vecht C J. Cyclosporine neurotoxicity: a review.  J Neurol. 1999;  246(5) 339-346
    CrossrefPubMedSearch in Google Scholar
  • 50 Morgan J C, Sethi K D. Drug-induced tremors.  Lancet Neurol. 2005;  4(12) 866-876
    CrossrefPubMedSearch in Google Scholar
  • 51 Tarsy D, Simon D K. Dystonia.  N Engl J Med. 2006;  355(8) 818-829
    CrossrefPubMedSearch in Google Scholar
  • 52 Németh A H. The genetics of primary dystonias and related disorders.  Brain. 2002;  125 695-721
    CrossrefPubMedSearch in Google Scholar
  • 53 Breakefield X O, Blood A J, Li Y, Hallett M, Hanson P I, Standaert D G. The pathophysiological basis of dystonias.  Nat Rev Neurosci. 2008;  9(3) 222-234
    CrossrefPubMedSearch in Google Scholar
  • 54 Fahn S, Bressman S B, Marsden C D. Classification of dystonia. In: Fahn S, Marsden CD, Delong M Dystonia 3: Advances in Neurology, Vol. 78. Philadelphia, PA; Lippincott-Raven Publishers 1998: 1-10
    Search in Google Scholar
  • 55 Miyajima H. Aceruloplasminemia. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=acp Accessed June 15, 2008
    Search in Google Scholar
  • 56 Danek A, Dobson-Stone C, Velayos-Baeza A. The phenotype of chorea-acanthocytosis: a review of 106 patients with VPS13A mutations.  Mov Disord. 2005;  20(12) 1678
    PubMedSearch in Google Scholar
  • 57 Walker R H, Danek A, Dobson-Stone C et al.. Developments in neuroacanthocytosis: expanding the spectrum of choreatic syndromes.  Mov Disord. 2006;  21(11) 1794-1805
    CrossrefPubMedSearch in Google Scholar
  • 58 Patterson M. Niemann-Pick disease Type C. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=npc Accessed July 20, 2008
    Search in Google Scholar
  • 59 Ekinci B, Apaydin H, Vural M, Ozekmekci S. Two siblings with homocystinuria presenting with dystonia and parkinsonism.  Mov Disord. 2004;  19(8) 962-964
    CrossrefPubMedSearch in Google Scholar
  • 60 Cerovac-Cosić N, Petrović I, Klein C, Kostić V. Delayed-onset dystonia due to perinatal asphyxia: a prospective study.  Mov Disord. 2007;  22(16) 2426-2429
    CrossrefPubMedSearch in Google Scholar
  • 61 Bhatt M H, Obeso J A, Marsden C D. Time course of postanoxic akinetic-rigid and dystonic syndromes.  Neurology. 1993;  43(2) 314-317
    CrossrefPubMedSearch in Google Scholar
  • 62 Barabas G, Tucker S M. Idiopathic hypoparathyroidism and paroxysmal dystonic choreoathetosis.  Ann Neurol. 1988;  24(4) 585
    PubMedSearch in Google Scholar
  • 63 Tan E K, Chan L L. Movement disorders associated with hyperthyroidism: expanding the phenotype.  Mov Disord. 2006;  21(7) 1054-1057
    CrossrefPubMedSearch in Google Scholar
  • 64 Siejka S J, Knezevic W V, Pullan P T. Dystonia and intracerebral calcification: pseudohypoparathyroidism presenting in an eleven-year-old girl.  Aust N Z J Med. 1988;  18(4) 607-609
    PubMedSearch in Google Scholar
  • 65 Jankovic J, Patten B M. Blepharospasm and autoimmune disease.  Mov Disord. 1987;  2(3) 159-163
    CrossrefPubMedSearch in Google Scholar
  • 66 Edwards M J, Trikouli E, Martino D et al.. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study.  Neurology. 2004;  63(1) 156-158
    PubMedSearch in Google Scholar
  • 67 Edwards M J, Dale R C, Church A J, Giovannoni G, Bhatia K P. A dystonic syndrome associated with anti-basal ganglia antibodies.  J Neurol Neurosurg Psychiatry. 2004;  75(6) 914-916
    CrossrefPubMedSearch in Google Scholar
  • 68 Rajagopalan N, Humphrey P R, Bucknall R C. Torticollis and blepharospasm in systemic lupus erythematosus.  Mov Disord. 1989;  4(4) 345-348
    CrossrefPubMedSearch in Google Scholar
  • 69 Revilla F J, Racette B A, Perlmutter J S. Chorea and jaw-opening dystonia as a manifestation of NeuroBehcet's syndrome.  Mov Disord. 2000;  15(4) 741-744
    CrossrefPubMedSearch in Google Scholar
  • 70 Fung V S, Duggins A, Morris J G, Lorentz I T. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia.  Mov Disord. 2000;  15(4) 732-734
    CrossrefPubMedSearch in Google Scholar
  • 71 Zwecker M, Iancu I, Zeilig G, Ohry A. Camptocormia: a case of possible paraneoplastic aetiology.  Clin Rehabil. 1998;  12(2) 157-160
    CrossrefPubMedSearch in Google Scholar
  • 72 Yebenes J G, Cantarero S, Tabernero C, Vazquez A V. Symptomatic dystonias. In: Watts R, Koller W Movement Disorders: Neurologic Principles and Practice. New York, NY; McGraw-Hill 2004: 541-567
    Search in Google Scholar
  • 73 Dressler D, Benecke R. Diagnosis and management of acute movement disorders.  J Neurol. 2005;  252(11) 1299-1306
    PubMedSearch in Google Scholar
  • 74 Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia.  J Clin Pharmacol. 2008;  48(3) 379-384
    PubMedSearch in Google Scholar
  • 75 Alarcón F, Zijlmans J C, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients.  J Neurol Neurosurg Psychiatry. 2004;  75(11) 1568-1574
    CrossrefPubMedSearch in Google Scholar
  • 76 du Plessis A J, Bellinger D C, Gauvreau K et al.. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery.  Pediatr Neurol. 2002;  27(1) 9-17
    CrossrefPubMedSearch in Google Scholar
  • 77 Nazabal E R, Lopez J M, Perez P A, Del Corral P R. Chorea disclosing deterioration of polycythaemia vera.  Postgrad Med J. 2000;  76(900) 658-659
    CrossrefPubMedSearch in Google Scholar
  • 78 Midi I, Dib H, Köseoglu M, Afsar N, Gunal D I. Hemichorea associated with polycythaemia vera.  Neurol Sci. 2006;  27(6) 439-441
    CrossrefPubMedSearch in Google Scholar
  • 79 Cardoso F, Vargas A P, Oliveira L D, Guerra A A, Amaral S V. Persistent Sydenham's chorea.  Mov Disord. 1999;  14(5) 805-807
    CrossrefPubMedSearch in Google Scholar
  • 80 Chorea, ballism, athetosis: phenomenology and etiology. In: Fahn S, Jankovic J Principles and Practice of Movement Disorders. 1st ed. Philadelphia, PA; Elsevier 2007: 393-407
    Search in Google Scholar
  • 81 Church A J, Cardoso F, Dale R C, Lees A J, Thompson E J, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.  Neurology. 2002;  59(2) 227-231
    PubMedSearch in Google Scholar
  • 82 Paz J A, Silva C A, Marques-Dias M J. Randomized double-blind study with prednisone in Sydenham's chorea.  Pediatr Neurol. 2006;  34(4) 264-269
    CrossrefPubMedSearch in Google Scholar
  • 83 Teixeira A L, Cardoso F, Maia D P, Cunningham M C. Sydenham's chorea may be a risk factor for drug induced parkinsonism.  J Neurol Neurosurg Psychiatry. 2003;  74(9) 1350-1351
    CrossrefPubMedSearch in Google Scholar
  • 84 Sanna G, Bertolaccini M L, Cuadrado M J et al.. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.  J Rheumatol. 2003;  30(5) 985-992
    PubMedSearch in Google Scholar
  • 85 Miranda M, Cardoso F, Giovannoni G, Church A. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies.  J Neurol Neurosurg Psychiatry. 2004;  75(2) 327-328
    PubMedSearch in Google Scholar
  • 86 Vela L, Sfakianakis G N, Heros D, Koller W, Singer C. Chorea and contraceptives: case report with PET study and review of the literature.  Mov Disord. 2004;  19(3) 349-352
    CrossrefPubMedSearch in Google Scholar
  • 87 Bordelon Y M, Smith M. Movement disorders in pregnancy.  Semin Neurol. 2007;  27(5) 467-475
    Thieme ConnectPubMedSearch in Google Scholar
  • 88 Vernino S, Tuite P, Adler C H et al.. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.  Ann Neurol. 2002;  51(5) 625-630
    CrossrefPubMedSearch in Google Scholar
  • 89 Kujawa K A, Niemi V R, Tomasi M A, Mayer N W, Cochran E, Goetz C G. Ballistic-choreic movements as the presenting feature of renal cancer.  Arch Neurol. 2001;  58(7) 1133-1135
    CrossrefPubMedSearch in Google Scholar
  • 90 Oh S H, Lee K Y, Im J H, Lee M S. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases.  J Neurol Sci. 2002;  200(1–2) 57-62
    CrossrefPubMedSearch in Google Scholar
  • 91 Chang M H, Li J Y, Lee S R, Men C Y. Non-ketotic hyperglycaemic chorea: a SPECT study.  J Neurol Neurosurg Psychiatry. 1996;  60(4) 428-430
    CrossrefPubMedSearch in Google Scholar
  • 92 Lai S L, Tseng Y L, Hsu M C, Chen S S. Magnetic resonance imaging and single-photon emission computed tomography changes in hypoglycemia-induced chorea.  Mov Disord. 2004;  19(4) 475-478
    CrossrefPubMedSearch in Google Scholar
  • 93 Hayashi R, Hashimoto T, Tako K. Efficacy of propranolol in hyperthyroid-induced chorea: a case report.  Mov Disord. 2003;  18(9) 1073-1076
    CrossrefPubMedSearch in Google Scholar
  • 94 Taurin G, Golfier V, Pinel J F et al.. Choreic syndrome due to Hashimoto's encephalopathy.  Mov Disord. 2002;  17(5) 1091-1092
    CrossrefPubMedSearch in Google Scholar
  • 95 Isaacs J D, Rakshi J, Baker R, Brooks D J, Warrens A N. Chorea associated with thyroxine replacement therapy.  Mov Disord. 2005;  20(12) 1656-1657
    CrossrefPubMedSearch in Google Scholar
  • 96 Lee E J, Park J H, Ihn Y, Kim Y J, Lee S K, Park C S. Acute bilateral basal ganglia lesions in diabetic uraemia: diffusion-weighted MRI.  Neuroradiology. 2007;  49(12) 1009-1013
    CrossrefPubMedSearch in Google Scholar
  • 97 Park J H, Kim H J, Kim S M. Acute chorea with bilateral basal ganglia lesions in diabetic uremia.  Can J Neurol Sci. 2007;  34(2) 248-250
    PubMedSearch in Google Scholar
  • 98 Topakian R, Stieglbauer K, Rotaru J, Haring H P, Aichner F T, Pichler R. Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment.  Mov Disord. 2006;  21(11) 2026-2027
    CrossrefPubMedSearch in Google Scholar
  • 99 Janavs J L, Aminoff M J. Dystonia and chorea in acquired systemic disorders.  J Neurol Neurosurg Psychiatry. 1998;  65(4) 436-445
    PubMedSearch in Google Scholar
  • 100 Cardoso F, Seppi K, Mair K J, Wenning G K, Poewe W. Seminar on choreas.  Lancet Neurol. 2006;  5(7) 589-602
    CrossrefPubMedSearch in Google Scholar

Christopher G GoetzM.D. 

Department of Neurological Sciences, Movement Disorders Section, Rush University Medical Center

1725 West Harrison Street, Suite 755, Chicago, IL 60612

Email: cgoetz@rush.edu